Key result
Cardiac computed tomography is a valuable imaging modality for assessing myocardial pathology and the sequelae of coronary artery disease, offering excellent patient compatibility and tolerability.
Why the study?
What is the value and limitation of cardiac computed tomography in the assessment of myocardial disease?
What is the value and limitation of cardiac computed tomography in the assessment of myocardial disease?
Cardiac CT serves as a valuable alternative imaging modality for the assessment of myocardial pathology, particularly when gold standard modalities like CMR or echocardiography are unsuitable.
The imaging of myocardial disease is of increasing importance for cardiologists from all subspecialties, for diagnosis, risk stratification, or to facilitate therapy. While the gold standard modalities for such assessment are cardiac magnetic resonance and echocardiography, these are not universally suitable. Cardiac computed tomography (CT), well-established for the assessment of coronary artery disease (CAD), can be of value in the assessment of myocardial pathology, due to excellent patient compatibility and tolerability, high spatial resolution, and acceptable tissue characterization. This review considers the value and limitations of CT in the assessment of the myocardial sequelae of CAD, and for patients with a variety of other cardiomyopathic diseases, depicts some of the common findings, and considers current developments in this area.
No takes yet. Share an insight, caveat, or question.
Clayton et al. (2014) conducted a review in Myocardial disease. Cardiac computed tomography (CT) vs. Cardiac magnetic resonance and echocardiography was evaluated. Cardiac computed tomography is a valuable imaging modality for assessing myocardial pathology and the sequelae of coronary artery disease, offering excellent patient compatibility and tolerability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: